0001745020-21-000002.txt : 20210204 0001745020-21-000002.hdr.sgml : 20210204 20210204122027 ACCESSION NUMBER: 0001745020-21-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210204 DATE AS OF CHANGE: 20210204 EFFECTIVENESS DATE: 20210204 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Theseus Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001745020 IRS NUMBER: 830712806 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-388439 FILM NUMBER: 21590022 BUSINESS ADDRESS: STREET 1: C/O ORBIMED ADVISORS LLC STREET 2: 601 LEXINGTON AVE., FL 54 CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2127396493 MAIL ADDRESS: STREET 1: C/O ORBIMED ADVISORS LLC STREET 2: 601 LEXINGTON AVE., FL 54 CITY: NEW YORK STATE: NY ZIP: 10022 D 1 primary_doc.xml X0708 D LIVE 0001745020 Theseus Pharmaceuticals, Inc. 210 Broadway, Suite 201 Cambridge MA MASSACHUSETTS 02139-3357 212-739-6493 DELAWARE None None Corporation true 2017 Iain Dukes 210 Broadway, Suite 201 Cambridge MA MASSACHUSETTS 02139-3357 Executive Officer Director William C. Shakespeare 210 Broadway, Suite 201 Cambridge MA MASSACHUSETTS 02139-3357 Director Carl Gordon c/o OrbiMed Advisors LLC 601 Lexington Ave. FL 54 New York NY NEW YORK 10022 Director Michael Rome c/o Foresite Capital 600 Montgomery Street, Suite 4500 San Francisco CA CALIFORNIA 94111 Director Pharmaceuticals Decline to Disclose 06b false 2021-01-22 false true false 0 100099954 95099957 4999997 false 16 0 0 0 false Theseus Pharmaceuticals, Inc. /s/ Iain Dukes Iain Dukes President and Chief Executive Officer 2021-02-04